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Diatomite is a natural fossil material of sedimentary origin, constituted by fragments of diatom siliceous skeletons.
In this preliminary work, the properties of diatomite nanoparticles as potential system for the delivery of drugs in
cancer cells were exploited. A purification procedure, based on thermal treatments in strong acid solutions, was
used to remove inorganic and organic impurities from diatomite and to make them a safe material for medical
applications. The micrometric diatomite powder was reduced in nanoparticles by mechanical crushing, sonication,
and filtering. Morphological analysis performed by dynamic light scattering and transmission electron microscopy
reveals a particles size included between 100 and 300 nm. Diatomite nanoparticles were functionalized by
3-aminopropyltriethoxysilane and labeled by tetramethylrhodamine isothiocyanate. Different concentrations
of chemically modified nanoparticles were incubated with cancer cells and confocal microscopy was performed. Imaging
analysis showed an efficient cellular uptake and homogeneous distribution of nanoparticles in cytoplasm and nucleus,
thus suggesting their potentiality as nanocarriers for drug delivery.
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Modern medicine has been revolutionized by the use of
micro/nanocarriers that, acting theoretically as ‘magic
bullets’ [1], operate in site-specific delivery mechanism
to spare normal cells and tissues. A kind of natural
microcarriers developed for innovative drug delivery is
represented by diatomite silica microparticles [2]. Di-
atomite is a fossil material of sedimentary origin formed
by fragments of diatom skeletons, called frustules. Frus-
tules of diatoms, single-cell photosynthetic algae largely
diffused in aquatic environments, are mainly constituted
by amorphous silica and are characterized by a specific
surface area up to 200 m2/g [3]. In nature, there are dif-
ferent kinds of diatoms (about 110,000 species) varying
in size (from 2 μm to 2 mm) and morphology [4]. The
low cost, abundance, easy availability, excellent biocom-
patibility, non-toxicity, thermal stability, and chemical
inertness make diatomite an intriguing material for sev-
eral applications ranging from filtration to pharmaceut-
ics [5-8]. Diatomite is composed by 70 to 90% of silica,* Correspondence: annalisa.lamberti@unina.it
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in any medium, provided the original work is pclay, some metallic oxides, such as Al2O3 and Fe2O3,
and other organic components [4]. Usually, diatomite
mined from geological deposits must be purified before
to be used; thermal pre-calcination and HCl washing are
the treatments generally used to increase powder quality
and to make the biomaterial inert as filter support
[9,10]. The diatomite silica surface presents reactive
Si-OH groups that can be chemically modified in order
to achieve a functionalized surface with proper chemical
groups, such as −NH2, −COOH, −SH, and −CHO, which
can be used for small interfering RNA (siRNA), micro-
RNA (miRNA), decoy oligo, and drug loading [11,12].
In the present work, diatomite nanoparticles (DNPs)
with a diameter lower than 300 nm were prepared by
mechanical crushing, sonication, and filtering of micro-
metric diatomite powder. Nanoparticles, once purified
from organic and inorganic impurities, were functional-
ized by using 3-aminopropyltriethoxysilane (APTES) and
labeled with tetramethylrhodamine isothiocyanate (TRITC)
in order to verify their cellular uptake. Confocal micros-
copy was used to investigate nanocarrier internalization
in lung epidermoid cancer cells (H1355). Results dem-
onstrated effective cellular uptake of nanoparticles ands an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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riers able to improve drug delivery.Methods
Materials
Calcined diatomite was obtained by DEREF S.p.A
(Castiglione in Teverina, Viterbo, Italy). 3-aminopro-
pyltriethoxysilane (APTES), H2SO4, and tetramethylr-
hodamine isothiocyanate (TRITC) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Phosphate-buffered
saline (PBS) was purchased from GIBCO (Carlsbad, CA,
USA). HCl was purchased from Romil (Cambridge, UK).
Absolute ethanol and H2O2 was purchased from Carlo
Erba (Milan, Italy); HEPES powder was purchased from
Promega (Madison, WI, USA).Purification of diatomite powder
Five grams of crashed diatomite rocks were resuspended
into 250 ml of absolute ethanol and sonicated for 5 h
to break large aggregates. The dispersion was sieved
through a nylon net filter with pore size of 41 μm, and
then filtered with pore size of 0.45 μm (Millipore, Billerica,
MA, USA). The diatomite nanopowder was purified to
remove organic and inorganic impurities [9,10]. The
sample was centrifuged and the pellet treated with
Piranha solution (2 M H2SO4, 10% H2O2) for 30 min
at 80°C. Nanoparticle dispersion was centrifuged for
30 min at 21,500 × g, washed twice with distilled water,
resuspended in 5 M HCl, and incubated over night
at 80°C. DNPs were then centrifuged for 30 min at
21,500 × g and washed twice with distilled water to
eliminate HCl residues.Characterization of nanoparticles size
The size and zeta-potential measurements of purified
diatomite nanoparticles dispersed in water (pH = 7)
were performed before and after APTES functionaliza-
tion by dynamic light scattering (DLS) using a Zetasizer
Nano ZS (Malvern Instruments, Malvern, UK) equipped
with a He-Ne laser (633 nm, fixed scattering angle of
173°, 25°C).
Transmission electron microscopy (TEM) and scanning
electron microscopy (SEM) were also used to investigate
nanoparticles morphology. Briefly, in TEM analysis, puri-
fied diatomite nanoshells were characterized by placing a
drop of suspension on a TEM copper grid with a lacy car-
bon film and then observed by a Jeol 1011 TEM (Peabody,
MA, USA) at an accelerating voltage of 100 KV. For SEM
characterization, diatomite samples were deposited on
crystalline silicon substrates mounted on a double-faced
conductive adhesive tape. Images were acquired at 5-kV
accelerating voltage and 30-μm wide aperture.Cell culture
The human lung epidermoid cancer cell line (H1355),
obtained from American Type Tissue Collection (Rockville,
MD, USA), was grown at 37°C with an atmosphere of 5%
CO2, in RPMI 1640 (GIBCO) medium supplemented with
10% heat inactivated FBS (GIBCO), 100 U/mL penicillin,
100 mg/mL streptomycin, 1% L-glutamine.
Diatomite functionalization
Purified nanoparticles were amino-modified with a 5%
(v/v) APTES solution in absolute ethanol [13,14]. The
APTES film formation was carried out for 1 h at room
temperature with stirring in a dark condition. After this
step, the sample was centrifuged for 30 min at 21,500 × g
and supernatant discarded. The functionalized diatomite
were washed twice with absolute ethanol and the col-
lected pellet was incubated for 10 min at 100°C (curing
process). Finally, the sample was washed twice with
absolute ethanol and twice with 20 mM HEPES buffer
pH 7.5.
Fourier-transform infrared spectroscopy
Chemical composition of APTES-functionalized diatom-
ite nanoparticles was analyzed by Fourier-transform in-
frared (FTIR) spectroscopy. Spectra were recorded by
a Thermo-Nicholet NEXUS Continuum XL (Thermo
Scientific, Waltham, MA, USA) equipped with a micro-
scope, at 2 cm−1 resolution on samples deposited on
silicon chips (p-type, 0.003 ohm cm resistivity, <100 > ori-
ented, 500-μm tick) of about 1 cm× 1 cm.
Nanopowder diatomite labeling
Diatomite labeling procedure was based on the use of an
aminoreactive molecule, tetramethylrhodamine isothio-
cyanate. TRITC powder was solved in dimethyl sulfoxide
(DMSO) and incubated with diatomite nanopowder in
the presence of NaHCO3 0.1 M pH 8.7 with stirring for
1 h at room temperature in a dark condition. Subse-
quently, the sample was washed with distilled water to
remove TRITC excess, until no fluorescence was re-
vealed in the supernatant when analyzed by fluorescence
microscopy. Labeled diatomite nanoparticles will be
indicated as DNPs*.
Confocal microscopy
H1355 cell line (20 × 103 cells/coverslip) was plated on
10-mm glass coverslips placed on the bottom of 24-well
plate, allowed to attach for 24 h under normal cell cul-
ture conditions, and then incubated with increasing
DNPs* concentration (5, 10, 15 μg/mL) for 24 h. As
negative control, the last supernatant obtained from
nanoparticles labeling procedure was added to the cells.
Cell nuclei and membranes were then stained with
Hoechst 33342 (Invitrogen, Carlslab, CA, USA) and
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quired at × 63 magnification on a LSM710 confocal
fluorescence microscope (Carl Zeiss Inc., Peabody, MA,
USA) with the appropriate filters. Cell fluorescence
intensity was analyzed by using ImageJ software (http://
imagej.nih.gov/ij/).
Results and discussion
Characterization of diatomite nanoparticles
Size and surface charge of purified diatomite nanoparti-
cles dispersed in water (pH = 7) were determined by
DLS. The average size and zeta-potential of nanoparti-
cles were 220 ± 90 nm and −19 ± 5 mV, respectively
(Figure 1). The negative value of zeta-potential is due
to the presence of silanol groups on nanoparticles sur-
face after treatment in Piranha solution.
Figure 2A shows a TEM image of purified diatomite
nanoshells. A heterogeneous population constituted by
nanostructures morphologically different in size and
shape can be observed. The histogram of particle size,
reported in Figure 2B and calculated from the picture
reported in Figure 2A (by using ImageJ software), re-
vealed a powder dimension ranging from 100 nm up to
300 nm with a maximum frequency value at 150 nm.Figure 1 Size (upper graph) and zeta potential (lower graph) distribuThe result was in agreement with that obtained by DLS
analysis. The pore size of diatomite nanoparticles was
estimated from SEM image reported in Figure 2C: pores
of about 30 nm can be observed. Compared to other
nanocarriers, the nanometric size and morphology of
these particles make them suitable in drug delivery
applications [15].
Diatomite powder functionalization
Hot acid-treated nanoparticles were functionalized with
APTES solution to allow an amino-silane coating on
their surface. The functionalization procedure is fully
sketched in Figure 3. Silanol groups on diatomite surface
were formed by hydroxylation using aqueous sulfuric
acid. APTES in organic anhydrous solvent reacted with
silanol groups on the activated surface producing silox-
ane linkages. Diatomite silanization was evaluated by
FTIR spectroscopy. The comparison between FTIR spec-
tra of bare nanoparticles (upper graph) and APTES-
functionalized powders (lower graph) is reported in
Figure 4. The peak of Si-O-Si bond at 1,100 cm−1, char-
acteristic of diatomite frustules, is well evident in both
spectra. Before APTES functionalization, it is also de-
tected the peak at 3,700 to 3,200 cm−1 corresponding totions of diatomite nanoparticles in water (pH = 7).
Figure 2 TEM image, particles size distribution and SEM image of purified diatomite nanoshells. Transmission electron microscopy image
of DNPs (A) and particles size distribution (B) calculated from (A). Scanning electron microscopy image of nanoparticle pores (C).
Figure 3 Functionalization scheme of diatomite nanoparticles with rhodamine (TRITC). APTES treatment allows surfaces substitution
of the hydroxyl groups with − NH2 reactive amino-groups. These chemical modifications allow binding between − NH2 and rhodamine
isothiocyanate group.
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Figure 4 FTIR spectra of nanoparticles before (upper graph) and after (lower graph) APTES functionalization.
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showed the silane characteristic peaks in the range be-
tween 1,800 and 1,300 cm−1 (see the inset of Figure 4);
in particular, the peak at 1,655, corresponding to imine
group and the peak at 1,440 cm−1, corresponding to
asymmetric deformation mode of the CH3 group, were
observed, according to results already reported [16,17].
FTIR characterization clearly demonstrated the silaniza-
tion of silica nanoparticles.
APTES-modified silica nanoparticles dispersed in water
(pH = 7) were also characterized by DLS analysis. A size
of 280 ± 50 nm and a zeta-potential of +80 ± 5 mV wereFigure 5 Confocal microscopy images and cell fluorescence intensity
different concentrations of DNPs* (A); scale bar corresponds to 20 μm. Cell
reported were obtained from fluorescence analysis of diatomite-TRITC imagdetermined (data not shown). The positive potential is
the result of protonation of amino groups on nanopar-
ticles surface [18].
Confocal microscopy analysis and DNPs* internalization
Nanoparticle cell uptake was studied by using DNPs*
and confocal microscopy analysis. H1355 cells have been
incubated with DNPs* at increasing concentrations (5,
10, 15 μg/mL) for 24 h. Figure 5A shows representative
confocal microscopy images of cells treated with DNPs*
compared to untreated cells as control. Cell nuclei were
stained with Hoechst 33342 (blue), cell membranes wereanalysis. Confocal microscopy image of H1355 cells incubated with
fluorescence intensity vs nanoparticles concentration (B); the values
es in panel (A).
Figure 6 Confocal microscopy image with different focal depth
of H1355 cells incubated with 10 μg/mL of DNPs*.
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were labeled with TRITC (red). Images show an increase
of fluorescence intensity at increasing DNPs* concentra-
tion and a homogeneous particles distribution in the
cytoplasm and into nuclei. The cell fluorescence inten-
sity vs labeled nanoparticles concentration is reported in
Figure 5B; fluorescence values were calculated for each
cell from the TRITC images of Figure 5A. Data showed
an increase of the fluorescence intensity up to about
10 μg/mL. A saturation of the signal can be observed for
nanoparticle concentrations higher than 10 μg/mL. To
prove the internalization of the carriers in the cells, im-
ages at different focal depth were recorded. Figure 6
shows that going from upper cell surface to the focus in-
side the cells, an increase of red diatomite fluorescence
can be observed thus indicating the uptake of DNPs* by
H1355 cells.
Conclusions
In this work, a procedure for preparing diatomite nano-
particles with an average size of 200 nm was described.
DNP morphology and surface chemical modifications
were investigated by DLS, SEM and TEM, and FTIR
analyses, respectively. Confocal microscopy experiments
revealed an efficient nanoparticle uptake into cytoplasm
of human epidermoid carcinoma cells. This preliminary
study demonstrates that the diatomite nanoparticles
could represent a promising tool for the delivery of anti-
cancer molecules such as siRNA, miRNA, and drugs in-
side cancer cells. Since APTES functionalization of the
nanoparticles showed the possibility to efficiently bind
amino-reactive groups (TRITC), the development of
chemical protocols for loading anticancer molecules rep-
resents a further step in order to finalize the use of
diatomite in medical applications. Moreover, it would
be expected that compared to other nanocarriers, theirselective targeted functionalization will improve the
delivery of anti-tumoral molecules to specific cell
population.
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